370 related articles for article (PubMed ID: 30607681)
1. High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies.
Rossignol J; Cozzi B; Liebaert F; Hatton S; Viallard ML; Hermine O; Greco C
Support Care Cancer; 2019 Aug; 27(8):3053-3059. PubMed ID: 30607681
[TBL] [Abstract][Full Text] [Related]
2. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors.
Gewandter JS; Mohile SG; Heckler CE; Ryan JL; Kirshner JJ; Flynn PJ; Hopkins JO; Morrow GR
Support Care Cancer; 2014 Jul; 22(7):1807-14. PubMed ID: 24531792
[TBL] [Abstract][Full Text] [Related]
3. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
[TBL] [Abstract][Full Text] [Related]
4. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
[TBL] [Abstract][Full Text] [Related]
5. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study.
Lynch ME; Clark AJ; Sawynok J; Sullivan MJ
J Pain; 2005 Oct; 6(10):644-9. PubMed ID: 16202956
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
Hou S; Huh B; Kim HK; Kim KH; Abdi S
Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
[TBL] [Abstract][Full Text] [Related]
7. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS
Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375
[TBL] [Abstract][Full Text] [Related]
8. Adhesive capsaicin 8% patch for improved control of pain caused by chemotherapy-induced peripheral neuropathy in patients with multiple myeloma: A single-centre, seven-case series.
Moreno-Alonso D; Llorens-Torromé S; Corcoy de Febrer B; Amandi García M; Serrano-Bermúdez G; Trelis-Navarro J; Mayoral-Rojals V; Serrano-Afonso A
J Oncol Pharm Pract; 2024 Jun; 30(4):752-758. PubMed ID: 38415287
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
Barton DL; Wos EJ; Qin R; Mattar BI; Green NB; Lanier KS; Bearden JD; Kugler JW; Hoff KL; Reddy PS; Rowland KM; Riepl M; Christensen B; Loprinzi CL
Support Care Cancer; 2011 Jun; 19(6):833-41. PubMed ID: 20496177
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
11. High doses of topical amitriptyline in neuropathic pain: two cases and literature review.
Kopsky DJ; Hesselink JM
Pain Pract; 2012 Feb; 12(2):148-53. PubMed ID: 21676162
[TBL] [Abstract][Full Text] [Related]
12. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.
Kim BS; Jin JY; Kwon JH; Woo IS; Ko YH; Park SY; Park HJ; Kang JH
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e448-e454. PubMed ID: 29280313
[TBL] [Abstract][Full Text] [Related]
14. Tapentadol in neuropathic pain cancer patients: a prospective open label study.
Galiè E; Villani V; Terrenato I; Pace A
Neurol Sci; 2017 Oct; 38(10):1747-1752. PubMed ID: 28699105
[TBL] [Abstract][Full Text] [Related]
15. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
Pachman DR; Barton DL; Watson JC; Loprinzi CL
Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
[TBL] [Abstract][Full Text] [Related]
17. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain.
Lynch ME; Clark AJ; Sawynok J
Clin J Pain; 2003; 19(5):323-8. PubMed ID: 12966259
[TBL] [Abstract][Full Text] [Related]
18. The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial.
Arslan S; Zorba Bahceli P; İlik Y; Artaç M
Eur J Oncol Nurs; 2020 Oct; 48():101827. PubMed ID: 32932009
[TBL] [Abstract][Full Text] [Related]
19. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
[TBL] [Abstract][Full Text] [Related]
20. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
